BERNADETTE MOMOH: Open Payments
NPI 1841400223 · CLAYMONT, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,700 in 30 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $897 · 2025 $1,700
Food & beverage: $1,700
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $421 |
| Otsuka America Pharmaceutical, Inc. | 7 | $339 |
| ABBVIE INC. | 3 | $258 |
| Axsome Therapeutics, Inc. | 2 | $245 |
| Alkermes, Inc. | 3 | $182 |
| Neurocrine BioSciences, Inc. | 6 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, Auvelity, INVEGA TRINZA, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA, LYBALVI, INGREZZA.
Industry payments across DE — which companies pay providers there.
